This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

McKesson (MCK) Receives a Buy from Barclays

Tipranks - Tipranks - Thu Jun 11, 4:28AM CDT

In a report released today, Glen Santangelo from Barclays maintained a Buy rating on McKesson, with a price target of $925.00.

Introducing TipRanks MCP for Agents

Santangelo covers the Healthcare sector, focusing on stocks such as Cencora, Medline, and Viatris. According to TipRanks, Santangelo has an average return of 3.7% and a 52.43% success rate on recommended stocks.

In a report released on June 8, Bank of America Securities also maintained a Buy rating on the stock with a $900.00 price target.

See today’s best-performing stocks on TipRanks >>

Based on McKesson’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $96.3 billion and a net profit of $1.68 billion. In comparison, last year the company earned a revenue of $90.82 billion and had a net profit of $1.26 billion

Read More on MCK:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).